Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.

Scutellaria baicalensis is a widely used Chinese herbal medicine that has been used historically in anti-inflammatory and anticancer therapy. The purpose of this study is to verify its anticancer activity on head and neck squamous cell carcinoma (HNSCC) in vitro and in vivo and to investigate its effect on cyclooxygenase-2 (COX-2), which converts arachidonic acid to prostaglandin E(2) (PGE(2)) and is highly expressed in HNSCC. Two human HNSCC cell lines (SCC-25 and KB) and a nontumorigenic cell line (HaCaT) were tested in vitro for growth inhibition, proliferation cell nuclear antigen expression, and COX-2 activity and expression after treatment with Scutellaria baicalensis extract. Its effects were compared with those of baicalein (a flavonoid isolated from Scutellaria baicalensis), indomethacin (a nonselective COX inhibitor), and celecoxib (a selective COX-2 inhibitor). Four nude mice with s.c. inoculation of KB cells were tested for its anticancer activity in vivo by oral administration of Scutellaria baicalensis at a dose of 1.5 mg/mouse (75 mg/kg), five times/week for 7 weeks. Scutellaria baicalensis and other agents demonstrated a strong growth inhibition in both tested human HNSCC cell lines. No growth inhibition of HaCaT cells was observed with Scutellaria baicalensis. The IC(50)s were 150 micro g/ml for Scutellaria baicalensis, 25 micro M for celecoxib, and 75 micro M for baicalein and indomethacin. Scutellaria baicalensis, as well as celecoxib and indomethacin, but not baicalein, suppressed proliferation cell nuclear antigen expression and PGE(2) synthesis in both cell types. Scutellaria baicalensis inhibited COX-2 expression, whereas celecoxib inhibited COX-2 activity directly. A 66% reduction in tumor mass was observed in the nude mice. Scutellaria baicalensis selectively and effectively inhibits cancer cell growth in vitro and in vivo and can be an effective chemotherapeutic agent for HNSCC. Inhibition of PGE(2) synthesis via suppression of COX-2 expression may be responsible for its anticancer activity. Differences in biological effects of Scutellaria baicalensis compared with baicalein suggest the synergistic effects among components in Scutellaria baicalensis.

[1]  F. Culo,et al.  Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer , 2005, Journal of Cancer Research and Clinical Oncology.

[2]  F. Ye,et al.  Anticancer activity of Scutellaria baicalensis and its potential mechanism. , 2002, Journal of alternative and complementary medicine.

[3]  Z. Kain,et al.  Attitudes of patients undergoing surgery toward alternative medical treatment. , 2002, Journal of alternative and complementary medicine.

[4]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[5]  R. Anderson,et al.  Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors , 2001, British Journal of Cancer.

[6]  S. Narumiya,et al.  Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice , 2001, Nature Medicine.

[7]  M. Marshall,et al.  Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[8]  Ling-Ling Yang,et al.  Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. , 2001, Biochemical pharmacology.

[9]  R. Kamijo,et al.  Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[10]  A. Levine,et al.  Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. , 2000, The Journal of urology.

[11]  T. Kanekura,et al.  Enhanced expression of cyclooxygenase (COX)‐2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX‐2 expression , 2000, International journal of cancer.

[12]  K. Sugimura,et al.  Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. , 2000, Urology.

[13]  J. Piccirillo,et al.  Head and neck squamous cell carcinoma: Better to be young , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[15]  T. Tanaka,et al.  Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, berberine, coptisine, palmatine, jateorrhizine and glycyrrhizin in Kampo medicines by ion-pair high-performance liquid chromatography. , 1999, Biological & pharmaceutical bulletin.

[16]  J. Shah,et al.  Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.

[17]  J. Faivre,et al.  Chemoprevention of colorectal cancer. , 1999, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[18]  C. Myers,et al.  Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Ondrey Arachidonic acid metabolism: a primer for head and neck surgeons. , 1998, Head & neck.

[20]  N Guthrie,et al.  Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. , 1997, Cancer letters.

[21]  N. Sawabu,et al.  Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. , 1994, Cancer letters.

[22]  M. Kojiro,et al.  The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. , 1994, Cancer research.

[23]  A. Hay,et al.  Inhibition of HIV infection by flavanoids. , 1993, Antiviral research.

[24]  M. Iinuma,et al.  Studies on inhibitors of skin tumor promotion. XI. Inhibitory effects of flavonoids from Scutellaria baicalensis on Epstein-Barr virus activation and their anti-tumor-promoting activities. , 1992, Chemical & pharmaceutical bulletin.

[25]  T. Konoshima,et al.  Studies on inhibitors of skin-tumor promotion. Inhibitory effects of triterpenes from Cochlospermum tinctorium on Epstein-Barr virus activation. , 1989, Journal of natural products.

[26]  T. Razina,et al.  [The role of thrombocyte aggregation function in the mechanism of the antimetastatic action of an extract of Baikal skullcap]. , 1989, Voprosy onkologii.

[27]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[28]  H. Lin,et al.  Prostaglandin synthesis by squamous carcinoma cells of head and neck, and its inhibition by non-steroidal anti-inflammatory drugs. , 1987, Journal of oral pathology.

[29]  J. Gray,et al.  Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. , 1986, Experimental cell research.

[30]  J. Celis,et al.  Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Juhn,et al.  Prostaglandins in squamous cell carcinoma of the head and neck: A preliminary study , 1985, The Laryngoscope.

[32]  Y. Kimura,et al.  Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. , 1984, Chemical & pharmaceutical bulletin.

[33]  Y. Kimura,et al.  Studies on Scutellariae Radix , 1981 .

[34]  Y. Kimura,et al.  Studies on Scutellariae radix. Part II: The antibacterial substance. , 1981, Planta medica.